Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/114480
DC FieldValueLanguage
dc.contributor.authorTavares, Aida Isabel-
dc.contributor.authorFerreira, Pedro Lopes-
dc.contributor.authorRaposo, Vítor-
dc.contributor.authorQuintal, Carlota-
dc.date.accessioned2024-03-28T10:27:13Z-
dc.date.available2024-03-28T10:27:13Z-
dc.date.issued2023-
dc.identifier.issn1661-8564pt
dc.identifier.urihttps://hdl.handle.net/10316/114480-
dc.description.abstractObjectives: Portugal liberalised the over-the-counter drugs market in 2005 and provides universal healthcare coverage in a mainly Beveridge-type health system. However, the COVID-19 pandemic has forced healthcare to change how services were delivered, especially increasing remote consultations in primary care. This analysis aims to find the drivers for taking non-prescribed drugs during the pandemic in Portugal. Specifically, it seeks to understand the role of taking prescribed drugs and attending remote medical appointments in the selfmedication decision. Methods: In this observational study, we used data collected during the pandemic in Centre Region of Portugal and estimated logistic regression for the whole sample and stratified by sex. Results: The main findings show that people taking prescribed medications and attending a remote consultation are more likely to take non-prescribed drugs. Also, reporting unmet healthcare needs seems to motivate people to choose selfmedication. Conclusion: Policy implications are pointed out concerning the health risks raised from self-medication, the role of the pharmacist advising non-prescribed drugs, and the related health risks arising from unmet healthcare needs.pt
dc.language.isoengpt
dc.publisherFrontiers Media S.A.pt
dc.relationFCT - Foundation for Science and Technology, I.P., under the Multiannual Financing of R&D Units 2020–2023pt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt
dc.subjectbehind-the-counter drugspt
dc.subjectnonprescription drugspt
dc.subjectsocial determinantspt
dc.subjectPortugalpt
dc.subjectCOVID-19pt
dc.subject.meshHumanspt
dc.subject.meshPortugalpt
dc.subject.meshNonprescription Drugspt
dc.subject.meshSelf Medicationpt
dc.subject.meshPandemicspt
dc.subject.meshCOVID-19pt
dc.titleConsumption of Non-Prescribed Drugs in Portugal During the Pandemic in 2021pt
dc.typearticle-
degois.publication.firstPage1606021pt
degois.publication.titleInternational Journal of Public Healthpt
dc.peerreviewedyespt
dc.identifier.doi10.3389/ijph.2023.1606021pt
degois.publication.volume68pt
dc.date.embargo2023-01-01*
uc.date.periodoEmbargo0pt
item.grantfulltextopen-
item.cerifentitytypePublications-
item.languageiso639-1en-
item.openairetypearticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextCom Texto completo-
crisitem.author.researchunitCEISUC - Center for Health Studies and Research of the University of Coimbra-
crisitem.author.researchunitCeBER – Centre for Business and Economics Research-
crisitem.author.researchunitCEISUC - Center for Health Studies and Research of the University of Coimbra-
crisitem.author.researchunitCeBER – Centre for Business and Economics Research-
crisitem.author.orcid0000-0003-3487-1202-
crisitem.author.orcid0000-0002-9448-9542-
crisitem.author.orcid0000-0002-9328-8415-
crisitem.author.orcid0000-0002-8306-3431-
Appears in Collections:I&D CeBER - Artigos em Revistas Internacionais
I&D CEISUC - Artigos em Revistas Internacionais
FEUC- Artigos em Revistas Internacionais
Show simple item record

Page view(s)

16
checked on May 8, 2024

Download(s)

4
checked on May 8, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons